Veradigm | MDRX - Selling And Administration Expenses

Stock Price
4.31
Daily Change
-0.19 -4.22%
Monthly
-6.30%
Yearly
-15.49%
Q1 Forecast
7.75

Veradigm reported $32.52M in Selling and Administration Expenses for its fiscal quarter ending in September of 2022.





Selling And Administration Expenses Change Date
Alcidion AUD 909K 12.94M Jun/2025
Ambu A/S DKK 689M 50M Dec/2025
Cardinal Health USD 1.5B 43M Dec/2025
Centene USD 3.37B 236M Dec/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Cigna USD 3.19B 242M Sep/2025
Computer Programs Systems USD 161.36M 1.74M Sep/2025
Convatec Group USD 420.3M 210.35M Dec/2024
Diasorin EUR 100.15M 18.26M Sep/2025
Elevance Health USD 10.91B 309M Dec/2025
General Electric Aerospace USD 1.58B 385M Dec/2025
Gulf Medical Proj AED 33.3M 3.39M Jun/2025
Humana USD 3.36B 614M Mar/2025
IQVIA Holdings USD 468M 46M Dec/2025
Laboratory Of America USD 538.6M 13.8M Dec/2025
Maximus USD 152.16M 35.52M Dec/2025
McKesson USD 2.03B 44M Dec/2025
Med Life RON 26.29M 643.42K Jun/2025
Molina Healthcare USD 1.33B 98M Dec/2025
Omnicell USD 107.36M 5.12M Dec/2025
Oriola-kd EUR 13M 3.1M Sep/2025
Owens Minor USD 462.35M 30.72M Mar/2025
Quest Diagnostics USD 504M 3M Dec/2025
Rede D'or Sao Luiz BRL 582.64M 40.73M Sep/2025
Siemens Healthineers EUR 925M 50M Dec/2025
Sonova Holding CHF 880.2M 300K Jun/2025
UnitedHealth USD 15.22B 1.44B Sep/2025
Veeva Systems USD 128.19M 9.41M Sep/2025
Veradigm USD 32.52M 27.13M Sep/2022
Xerox USD 368M 10M Jun/2025